Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Maturitas|September 29, 2009
Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER StudyElodie Bouaziz, Marianne Canonico, Céline Verstuyft, et al.
Atherosclerosis|December 17, 2002
Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) studyGrégoire Le Gal, Véronique Gourlet, Patricia Hogrel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 13, 2013
Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly womenJoanne Ryan, Isabelle Carrière, Helene Amieva, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 2, 2011
Oestrogen receptor polymorphisms and late-life depressionJoanne Ryan, Jacqueline Scali, Isabelle Carrière, et al.
Journal of Affective Disorders|November 5, 2011
Estrogen receptor alpha gene variants and major depressive episodesJoanne Ryan, Jacqueline Scali, Isabelle Carrière, et al.
Menopause (New York, N.Y.)|June 14, 2013
Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trialsMarianne Canonico, Geneviève Plu-Bureau, Mary Jo O'Sullivan, et al.
Atherosclerosis|December 17, 2002
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME studyPierre-Yves Scarabin, Dominique Arveiler, Philippe Amouyel, et al.
Thrombosis and Haemostasis|October 4, 2002
Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?Emmanuel Oger, Karine Lacut, Grégoire Le Gal, et al.
Neurology|January 31, 2014
High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal womenLaure Carcaillon, Sylvie Brailly-Tabard, Marie-Laure Ancelin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort studyValérie Scarabin-Carré, Sylvie Brailly-Tabard, Marie-Laure Ancelin, et al.
Pageof 6